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Bacteria communicate with one another via specialized signaling molecules, known
as quorum sensing molecules or autoinducers. The Pseudomonas aeruginosa-derived
quorum sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone (AHL-12), how-
ever, also activates mammalian cells. As shown previously, AHL-12-induced chemotaxis,
up-regulated CD11b expression, and enhanced phagocytosis of polymorphonuclear neu-
trophils. Circumstantial evidence concurred with a receptor for AHL-12, which has been
elusive so far. We now investigated the bitter receptor T2R38 as a potential candidate.
Although identified as a taste receptor, extragustatory cells express T2R38, for example,
epithelial cells in the lung. We now detected T2R38 in peripheral blood neutrophils,
monocytes, and lymphocytes. T2R38 is not only found on the cell membrane but also
intracellular. In neutrophils, T2R38 was located in vesicles with characteristics of lipid
droplets, and super-resolution microscopy showed a co-localization with the lipid droplet
membrane. Neutrophils take up AHL-12, and it co-localized with T2R38 as seen by laser
scan microscopy. Binding of AHL-12 to T2R28 was confirmed by pull-down assays using
biotin-coupled AHL-12 as bait. A commercially available antibody to T2R38 inhibited bind-
ing of AHL-12 to neutrophils, and this antibody by itself stimulated neutrophils, similarly to
AHL-12. In conclusion, our data provide evidence for expression of functional T2R38 on
neutrophils, and are compatible with the notion that T2R38 is the receptor for AHL-12.
Keywords: neutrophils, N-(3-oxododecanoyl)-L-homoserine lactone, quorum sensing, bitter receptor T2R38, lipid
droplets, Pseudomonas aeruginosa
Introduction
The quorum sensingmolecule,N-(3-oxododecanoyl)--homoserine lactone (AHL-12), is produced
by Pseudomonas aeruginosa and other Gram-negative bacteria. AHL-12 participates in the genera-
tion of virulence factors, and is particularly well studied in the context of biofilm formation (1–4).
Of note, for AHL-12, a so-called “interkingdom-signaling” was reported, defined as activation of
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mammalian cells by bacterial signaling molecules (5, 6). Inhibi-
tion of various lymphocyte functions by AHL-12 was reported
(7, 8), and was interpreted as a down-regulation of the immune
response (9). On the other hand, we and others described acti-
vation of phagocytic cells, including enhancement of phagocy-
tosis, increased expression of adhesion receptors, and induction
of chemotaxis (10–12), leading to the presumption that recog-
nition of AHL-12 might reinforce the local immune defense by
preventing biofilm formation [reviewed in Ref. (13)].
AHL-12 is highly hydrophobic. For T cells and model lipid
membranes, free diffusion through membranes was reported (14,
15). A nuclear receptor, PPARγ, was described in epithelial cells,
although physical binding of AHL-12 to PPARγ has not yet been
proven (16). In macrophages and neutrophils, the AHL-12 sig-
naling pathway was compatible with that of a G-protein coupled
receptor, whereas participation of toll-like receptors could be
excluded (11, 13, 17–20), a receptor, however, has not yet been
identified.
More recently, effects of AHL-12 on epithelial cells were
described, such as enhanced ciliary movement and NO-
production (21), indicating that AHL-12 induces activation of
defense-related functions in these cells. On airway epithelial cells,
the so-called bitter receptor T2R38 has been indicated as receptor
forAHL-12, and there is evidence for a correlation betweenT2R38
receptor allotypes and susceptibility to airway infections (21–23).
The bitter receptor T2R38 belongs to a family of taste recep-
tors. As the name implies, the receptor is sensing bitter tasting
substances, a phenomenon that is thought to prevent the intake
of bitter and potentially toxic substances [reviewed in Ref. (24–
27)]. Bitter receptors were first described on cells of the taste buds
in the oral cavity. Meanwhile, a wider distribution was reported,
e.g., expression on epithelial cells of the airways, in the colon, in
the brain, and in tumor cells as well (21, 28–30). The role of T2R38
in tissue outside the gustatory systems is still elusive, and so far,
AHL-12 appears to be the first natural ligand for T2R38, which
leads to the notion that T2R38 participates in “sensing of bacteria.”
In that context, we now addressed the question whether T2R38
could also be the receptor for AHL-12 on neutrophils.
Materials and Methods
Human Blood and Human Neutrophils
Blood from volunteers (mainly laboratory personal and students)
was drawn into heparin-coated tubes (Sarstedt, Nümbrecht, Ger-
many). Neutrophils were isolated by PolymorphPrep™(Axis-
Shield, Oslo, Norway) and residual erythrocytes were removed
by hypotonic lysis. The remaining cells were suspended in Hanks
balanced salt solution (HBSS), containing 0.5% bovine serum
albumin (BSA), at a final concentration of 5 106 cells/ml. This
procedure yielded 85–95% neutrophils as judged by cytofluorom-
etry using CD66b as marker for neutrophils. Written informed
consent was obtained from the volunteers and the ethic committee
of the University of Heidelberg approved the procedure.
Cell Lines
U937 and HL-60 were purchased from ATCC. The cell lines
were propagated in RPMI, containing fetal calf serum (10%),
-glutamine (1%), and penicillin-streptomycin (1%) (all pur-
chased from Gibco, Eggenstein, Germany). The cells were used
in their exponential growth phase. Differentiation of U937 was
induced by phorbol ester (100 ng/ml); HL-60 was differentiated
with DMSO (1.5%).
Antibodies
The following antibodies to T2R38 were used: bs-86508-A488
[rabbit (rb)IgG, labeledwith Alexa Fluor 488, Bioss,Woburn,MA,
USA]; ab65509 (rb serum); ab 130503 (rb IgG) (both obtained
from abcam, Cambridge, UK); sc-76108 (rb IgG), and sc-34294
(goat IgG) (Santa Cruz, Dallas, TX, USA). Isotype controls were
rb IgG labeled with Alexa Fluor (bs-0295P-A488, Bioss, Woburn,
MA, USA); rabbit IgG (b176094, abcam), or goat IgG (sc-3887,
Santa Cruz). Rabbit serum was obtained from our animal facility.
Secondary antibodies were FITC-labeled anti-rb IgG from goat
(111-096-003, Dianova, Hamburg, Germany) or Alexa Flour 488-
labeled anti-goat IgG from life technologies (A11055, Darmstadt,
Germany). CD11b expression was determined using a FITC-
labeled-antibody (IM0530, Beckman Coulter, Germany Krefeld).
The antigen peptide, sc-34294P, used to raise the antibody to
T2R38 (sc-34294), was purchased from Santa Cruz.
Cytofluorometry
To determine the expression of surface receptors on neutrophils,
whole blood (100μl) or isolated neutrophils (107/ml) were pre-
incubated with an Fc-receptor blocking agent (Biolegend 422302,
SanDiego, CA, USA), then incubated with the respective antibod-
ies or isotypic antibodies. In the whole blood assays, erythrocytes
were lyzed using BD Facs Lysing solution (BD Biosciences, NJ,
USA). Cells were subjected to cytofluorometry using FACSCal-
ibur and CellQuest Pro software (Becton Dickinson, Heidelberg,
Germany). For intracellular staining, the cells were treated with
FACS Permeabilizing Solution 2 (BD Biosciences), pre-incubated
with the Fc-receptor blocking agent and then incubated with
anti-T2R38 (2μg), as described above.
Uptake of AHL-12 and Inhibition Experiments
Isolated neutrophils (1 106/ml) in HBSS, containing 1%
BSA and 0.1% sodium azide (“FACS buffer”) were incubated
with AHL-FITC (Cayman Chemical, Ann Arbor, MI, USA)
(50–100μM) for 30min at 4°C, and then subjected to
cytofluorometry. For inhibition experiments, isolated neutrophils
were washed with FACS buffer and incubated with antibodies to
T2R38 for 30min at 4°C, or with the antigen peptide (2–4μg).
AHL-FITC (100μM) was added and after for 30min at 4°C,
fluorescence associated with the cells was measured.
Detection of T2R38
A test kit (SEF811Hu) was purchased from Cloud Clone Corpo-
ration, Houston, TX, USA, and the test was carried out according
to the protocol supplied.
Gene Expression Analysis
DNA was isolated from 106 purified neutrophils using the Mag-
naPure mRNA Isolation Kit I. mRNA was isolated with the
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MagnaPure-LC device. An aliquot of mRNA was reversely tran-
scribed using AMV-RT and oligo-dT as primer (First Strand
cDNA synthesis kit, Roche) according to the manufactures proto-
col. For PCR analysis, primer sets optimized for the LightCycler®
(RAS, Mannheim, Germany) were developed by and purchased
from SEARCH-LC GmbH (www.Search-LC.com). The PCR was
performed with the LightCycler® FastStart DNA Sybr GreenI kit
(RAS). To correct for differences in the content of mRNA, the
calculated transcript numbers were normalized according to the
expression of the housekeeping gene peptidylprolyl isomerase B
(PPIB). Values represent number of transcripts per 1000 tran-
scripts of PPIB.
Western Blot and Pull-Down Assays
Isolated neutrophils or HL-60 (107 cells) were lysed with RIPA
buffer (Tris-buffered saline containing 1% Non-idet P-40, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulfate, 0.0004%
sodium azide, 0.2M orthovanadate, and 0.5M phenylmethyl-
sulfonyl fluoride). Of each sample, 25μl were mixed with 5μl 5
Laemmli-buffer and applied to a SDS-Gel (9%). Following blot-
ting, the membrane was incubated with 5% milk powder in TBS,
containing 0.1% Tween20. Of the antibody to T2R38 (sc-34294) a
1:1000 dilution was used, of antigen peptide sc-34294P 0.5/10μl
antibody. Secondary antibody was a POX conjugated mouse anti-
goat IgG (#205-035-108, Jackson Immuno Research, Suffolk, UK,
1:20,000). Blots were developed using Amersham Prime Western
Blotting detection Reagent (GE Healthcare, Freiburg, Germany).
For the pull-down assay, neutrophils or HL-60 (2 107) were
lysed in RIPA buffer (2ml) and incubated overnight at 4°C with
or without AHL-12-biotin (300μM; Cayman Chemical). Then
streptavidin sepharose beads (Cell signaling, Danvers, MA, USA)
were added for 2 h at 4°C, then washed with PBS, and incu-
bated with SDS loading buffer containing β-mercaptoethanol.
The samples were applied to a 12% SDS-Gel. Silver staining was
performed andWestern blotting using sc-34294 and the respective
antigenic peptide. Alternatively, to whole cell lysate, membrane
proteins were extracted using the kit supplied by Calbiochem for
transmembrane proteins (#71772-3, Merck, Darmstadt). Extracts
of 4–5 107 cells were used (neutrophils or HL-60, as indicated
in the respective experiments).
Isolation of Lipid Droplets
Essentially, the method described by Wan et al. (31) was
used. In brief, 3 108 U937 cells were suspended in 3ml
ice-cold disruption buffer [25mM Tris-HCl pH 7.4, 5mM
EDTA, 1mM EGTA, 0.2mM PMSF, 50μg/ml N-α-p-tosyl--
lysin-chloromethyl-ketone (TLCK), 1μg/ml leupeptin, 1μg/ml
pepstatin, 1μg/ml aprotinin] and lysed by nitrogen cavitation
(10min, 800 psi, 4°C). The lysate was mixed with an equal volume
of 1.08M sucrose in disruption buffer without TLCK, centrifuged
for 30min, 1000 g at 4°C, to eliminate nuclei and intact cells
and then subjected to sucrose density centrifugation. After cen-
trifugation (3.5 h, 34,000 rpm, 4°C), the lipid droplets were in
the fraction with 0.54M sucrose. This fraction was diluted to
0.35Msucrosewith 0.15MNaCl, overlaidwith sucrose (0.27, 0.135
and 0M) for a second ultracentrifugation step (34,000 rpm, 4°C,
3.5 h). Lipid droplets were now in the fractionwith 0.35M sucrose.
Droplets could be recognized by fluorescence microscopy after
having incorporated Nile red (see below). For Western blotting,
the proteins were precipitated with methanol/chloroform, resus-
pended in Laemmli Buffer (95°C for 10min) and applied to a 12%
SDS-Gel. Silver staining andWestern blotting was performed was
described above.
Laser Scan Microscopy
To assess binding of AHL-12 to cells and co-localization of T2R38,
neutrophils were incubated with AHL-12-FITC (50μM, 20min at
4°C), placed on cover slips, and fixed with 2% PFA for 15min.
Then, anti-T2R38 [ab65509 (diluted 1:300) or sc-34294 (4μg)]
with the respective secondary antibodies (Alexa Fluor 488-labeled
anti-rabbit IgG fromdonkey (bs-0295D-A488, Bioss); Alexa Fluor
488 Donkey anti-goat IgG (life technologies, Carlsbad, CA, USA)
were added, and for comparison rabbit serum or goat IgG. The
samples were mounted with Moviol (Sigma-Aldrich, St. Louis,
MO, USA) and viewed by Laser Scan microscopy (LSM) (Nikon)
using a 40 objective. To detect lipid droplets and the association
of T2R38 with the droplets, neutrophils cells were placed on
slides by cytospin, fixed with ice-cold methanol for 5min and
washed with PBS. Nile red (Sigma-Aldrich) was added (10μg/ml
20min, room temperature), and after washing Hoechst 33342
nuclear stain was applied (H3570, life technologies, Darmstadt,
Germany) 1:10,000 for 10min. The samples were embedded with
Moviol. To visualize T2R38, 5% goat serum was used as block-
ing agent and anti-T2R38 (ab65509) in a dilution of 1:300 (for
comparison, normal rabbit serum was used). After 30min, the
secondary antibody was applied for 30min, then Nile red was
added (10μg/ml, 20min). In addition, experiments with anti-
T2R38 (sc-34294) were performed. In parallel, the antibody was
added to the cells together with the peptide sc-34294P. Droplets
were visualized by LSM and structured illumination microscopy
(SIM) (D-Structured Illumination Microscopy), respectively.
Phagocytosis
A commercially available kit (Glycotope Biotechnology, Heidel-
berg, Germany) with FITC-labeled bacteria was used according
to the instructions supplied.
Migration Assays
Chemotaxis was determined using the BDFalconHTS Fluoroblok
96-Multiwell Insert Systemwith an insert PETmembrane of 3μm
pore size. Isolated polymorphonuclear neutrophils (PMNs) were
labeledwith calcein. Cells (106 cells/ml)were incubated for 15min
at 37°Cwith calcein (life technologies; 1μg/ml), then washed with
HBSS and seeded in a concentration of 2 105/50μl into the
insert plate. AHL-12, PTU (100μM), and for comparison HBSS
or fMLP (10 7M)were added to the lower wells. After 2 h at 37°C,
the insert plate was removed and cell-associated fluorescence was
determined by a Perkin Elmer Wallac Victor 2 Microplate Reader
using Wallac Workstation software.
For the “under-agarose” migration assay, cover slips
(1.5 4 cm) were pretreated with 3M HCl and ethanol (95%).
Following washing with water, gelatine (0.5% in RPMI) was
applied as a thin film. The cover slips were air dried, then agarose
(1% in RPMI) was added (3ml per cover slip). When the agarose
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was solid, two holes were punched in a distance of 5mm. Cells
were placed in one hole (5 104 in 50μl), in the other the
chemokine to be tested. After 2 h at 37°C, the cells were fixed with
methanol for 30min, the agarose was removed and the remaining
cells were stained by Giemsa an examined microscopically.
Results
Expression of the Bitter Receptor T2R38 on
Neutrophils and Monocytes
T2R38 was detected on neutrophils, monocytes, and to a lesser
extent on lymphocytes in whole blood samples by cytofluo-
rometry. Comparing samples of seven individuals, a consider-
ably variation was seen (Figures 1A,B). Data obtained with the
T2R38 antibody sc-34294 are shown, however, antibodies directed
against other epitopes within the N-terminus of T2R38 (sc-67108;
ab65509) gave essentially similar results (data not shown). For the
antibody sc-34294, the antigenic peptide used to raise the anti-
body was available. This peptide inhibited binding of the antibody
to the cells by 50% (Figure 1C). An antibody directed against an
amino acid sequence of the C-terminus (ab130503) reacted only
with permeabilized cells (Figure 1D). ByWestern blotting, T2R38
was detected in whole cell lysates and in cell membrane prepa-
rations. Specificity of the antibody binding was controlled by the
antigenic peptide. In cell membranes, two bands with an apparent
molecularweight of 90 and 50 kDawere detected, in the cell lysates
multiple bands at 100, 90, 55, and 50 kDa, respectively (Figure 1E).
The expected molecular weight of T2R38 is 38 kDa, but post-
translational modifications and polymerization are described (for
these experiments, sc-34294 was used).
T2R38 was also expressed by U937 and HL-60 cells (data not
shown). Following differentiation of HL-60 by DMSO surface
expression of T2R38 increased moderately (39.9% increase of the
mean fluorescence intensity; average of three experiments).
The distribution of T2R38 in neutrophils was analyzed by con-
focal LSM. Accumulation at the membrane was seen and a speck-
led pattern in the cytoplasm (images with two different antibodies
are shown in Figure 2). The latter finding was compatible with
the notion that intracellular T2R38 was associated with membra-
nous vesicles and/or granules. Stimuli known to induce degran-
ulation, including IL8, f-MLP, C5a, or phorbol ester, did not
up-regulate surface expression of T2R38 when applied under
conditions causing up-regulation of CD11b.Moreover, T2R38was
not released into the cell supernatant as determined by ELISA
FIGURE 1 | Expression of T2R38 on peripheral blood cells.
(A) Cytofluorometry using the antibody sc-34294 (thick line) showed
expression of T2R38 [the gates were set according to the cell populations
identified by expression of CD66b (neutrophils), CD14 (monocytes), and CD3
(lymphocytes)]. For comparison goat IgG (thin line) was used. (B) T2R38 was
determined by cytofluorometry on peripheral blood cells of seven individuals
(each represented by a symbol) and mean fluorescence intensity (MFI) is
shown. The rectangles contain the data for the antibody isotype binding.
(C) T2R38 was also seen on isolated neutrophils (thick line) and binding of
the antibody could be inhibited by the specific antigen peptide (thin line)
(D) The antibody to T2R38 that recognizes the C-terminal domain of the
receptor (ab130503) reacts only following permeabilization of the cells.
(E) Western blot of neutrophil lysates with anti-T2R38 (sc-34294) revealed
multiple bands. Intensity of bands with an apparent molecular weight of
90–100 kDa was reduced by the antigen peptide sc-34294p, as was the
intensity of bands at 50–55 kDa (actin was used as loading control). Isolated
membranes showed only two protein bands at approximately 90 and 50 kDa
(CD11b was used as loading control). (Lysates and membranes were run on
different gels, and are aligned here according to the molecular weight
markers) (one of four blot is shown).
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FIGURE 2 | Distribution of T2R38 on neutrophils: by laser scan
microscopy, T2R38 was detected in neutrophils. The upper panel shows
an image with anti-T2R38 sc-34294 (green) and nuclei are stained in blue.
Binding of the antibody was partly inhibited by the antigen peptide. The
antibody ab65509 (lower panel) also detected T2R38 (green), in association
with the membrane, and with a speckled pattern intracellular. The lower right
panel shows the image obtained with rabbit serum instead of the antibody
(images were taken with 40 objective; digital zooms of representative areas
are shown in the insets).
FIGURE 3 | Association of T2R38 with lipid droplets: (A) shows
neutrophils stained with Nile red to visualize the lipid droplets; nuclei are
in blue. (B) With anti-T2R38 (green) and staining with Nile red, droplets
containing T2R38 can be recognized within the cell (marked by arrows).
(C) A SIM image of the area in the rectangle shows two lipids droplets with a
distinct yellow staining of their membranes, indicative of a close association of
T2R38 with the droplet membrane. (D) The images show isolated lipid droplets
stained with Nile red and anti-T2R38; localization of T2R38 on the droplets
membrane is seen especially in the zoomed image (E). (F) shows a blot of
isolated droplets with ab65509.
(data not shown). The failure tomobilize T2R38makes its location
in granules unlikely. Hence, we assessed association of T2R38
with lipid droplets. Neutrophils contain numerous lipid droplets
visualized by incorporation of Nile red (Figure 3A). Confocal
LSM indicated an association of T2R38 with droplets, particularly
with their membrane (Figure 3B). To support this finding, we
performed SIM. The circular morphology of the droplets could be
resolved by this super-resolution microscopy, and T2R38 clearly
was seen on the droplet membrane (Figure 3C). To verify the
association of T2R38 with lipid droplets further, droplets were
isolated by density centrifugation following the protocol by Wan
et al. (31). Droplets of different sizes were seen, and again an
association of T2R38 with the droplet membrane (Figures 3D,E).
Lysates of the droplet fraction were positive for T2R38 as tested by
blotting (Figure 3F).
Effect of Antibodies to T2R38 on
AHL-12-Mediated Function
To answer the most pertinent question whether T2R38 might
function as a receptor for AHL-12, the effect of antibodies to
T2R38 on AHL-12 binding and AHL-12-induced neutrophil acti-
vation was tested. For these experiments, FITC-labeled AHL-12
was used. AHL-12-FITC binds to neutrophils, as seen by cytoflu-
orometry and confocal LSM (Figures 4A,B). Binding of AHL-12-
FITC could be inhibited by anti-T2R38 (sc-34294), on average by
35%, when 4μg antibody were used per 1 106 neutrophils/ml
(mean of three experiments with cells of different individuals).
With higher antibody concentrations, also the isotype control was
inhibitory, precluding the correct interpretation of the data. The
other antibodies to T2R38 (sc-67108 and ab65509) did not inhibit
AHL-12 binding.
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FIGURE 4 | Uptake of AHL-12-FITC by neutrophils and activation
of cells: laser scan microscopy (A) and cytofluorometry (B)
revealed binding of AHL-12-FITC to neutrophils (thin line). Binding
could be inhibited by anti-T2R38 (sc-34294) (thick line) (C) AHL-12-FITC
induced migration of neutrophils shown by “under-agarose” migration
(cells are stained in blue), as did PTU. In comparison to f-MLP, fewer cells
had migrated but had covered a greater distance. (D) Chemotaxis (here
migration through porous membrane is shown; data with neutrophils of
seven individuals are summarized) was induced by AHL-12, PTU, f-MLP,
and compared to the random migration. Because endpoint was
measured, the number of cell migrating toward f-MLP was considerably
higher.
Next, the effect of the antibody sc-34294 on AHL-12-mediated
activation of neutrophils was assessed. Induction of chemotaxis
was measured, enhancement of phagocytosis, and up-regulation
of CD11b. Chemotaxis in response to AHL-12 was not inhib-
ited, nor was migration toward PTU, which is widely used as
ligand for T2R38, and which also induced chemotaxis of neu-
trophils (data based on two different methods, under-agarose
migration and migration through a filter membrane, are shown
in Figures 4C,D). Furthermore, the antibody did not inhibit the
AHL-12 mediated up-regulation of CD11b nor the enhancement
of phagocytosis. Rather, the antibody sc-34294 by itself activated
neutrophils. Following antibody binding surface expression of
CD11b was enhanced (on average by 1.7-fold; mean of three
experiments), as was the oxidative burst elicited by phagocyto-
sis of opsonized E. coli (on average by 3.5-fold) (examples in
Figures 5A,B).
Association of AHL-12 with T2R38 on Neutrophils
When neutrophils were incubated with limited amounts of AHL-
12-FITC (50μM) at 4°C and then incubated with anti-T2R38,
confocal LSM revealed a close proximity of AHL-12 and T2R38
(Figures 6A,B), suggesting a physical association of AHL-12 and
T2R38. “Pull-down” assays using biotin-labeled AHL-12 as bait
were performed with lysates of neutrophils or HL-60. Cell lysates
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FIGURE 5 | Antibodies to T2R38 activate neutrophils. (A) The antibody
sc-34294-induced up-regulation of CD11b on neutrophils (thick line; the thin
shows constitutive CD11b expression) and (B) it enhanced the phagocytosis
of FITC-labeled bacteria, measured as increase of cell-associated
fluorescence intensity (thick line; the thin line shows phagocytosis in presence
of the isotype IgG).
were incubated with AHL-12-biotin, and then with streptavidin
beads. Eluates from the beads yielded numerous proteins. By
Western blotting T2R38 could be identified with an apparent
molecular weight of 100 and 60 kDa (data for neutrophils and for
HL-60 are shown Figure 6C). When the pull-down assay with
AHL-12-biotin was carried with membrane protein fractions,
T2R38 could be detected again by Western blotting (Figure 6C).
Discussion
Our data provide evidence for an extragustatory expression of
the bitter taste receptor T2R38 on neutrophils, monocytes, and
myeloid cell lines. By a variety of methods and with antibodies
directed against different epitopes, intracellular expression as well
as expression on the cell membrane was seen. At difference with
the predicted molecular weight of 38 kDa, proteins with higher
apparent molecular weight were detected, presumably the result
of post-translational modifications and polymerization of the
receptor, as it had been described for T2R38 in epithelial cells (32).
Surface expression of T2R38 varied among individuals, as did
the number of gene transcripts. We presume a genetic predis-
position, because multiple testing revealed individuals express-
ing little T2R38 and others expressing moderate levels (own
unpublished data). The histograms obtained by cytofluorometry
revealed a more or less symmetric peak, indicating that T2R38
expression was not restricted to a subpopulation. The number of
FIGURE 6 | Co-localization of AHL-12 and T2R38: neutrophils were
incubated with AHL-12-FITC, placed on slides, fixed, and incubated
with either (A) anti-T2R38 or (B) isotypic antibody. Laser scan
microscopy shows co-expression of T2R38 and AHL-12-FITC as “yellow
cells.” The isotypic antibody shows some background staining, but the
majority of cells remained “green.” Selected areas (white rectangles) were
zoomed to show details. (C) A pull-down assays showed binding of AHL-12
to T2R38: AHL-12-biotin was incubated with neutrophils; then lysates were
prepared, and incubated with streptavidin beads, and the eluates were
subjected to SDS-PAGE and Western blotting using anti-T2R38 sc-34294
(lanes marked with +). In comparison to neutrophils having not been exposed
to AHL-12-biotin (lanes marked with  ), major bands were seen, at
100–130 kDa, and 55 kDa, the intensity of which could be reduced with the
specific antigen peptide. Experiments with HL-60 showed essentially similar
results. Here, membrane preparations are shown.
gene transcripts was rather low. Absent or marginal gene tran-
scription – even for highly expressed proteins – is not unusual
for neutrophils, because in these cells a great majority of pro-
teins is produced during maturation only, and are then stored in
intracellular compartments (33, 34).
Well-characterized storage compartments of neutrophils are
granules, which are generated as the precursor cells mature,
and which enclose proteins as they are synthesized [reviewed
in Ref. (34, 35)]. Release of proteins from those compartments
is accomplished by a number of mediators, including IL-8, f-
MLP, C5a, or phorbol ester (36). Because these compounds failed
to mobilize T2R38, we looked for other storage compartments
and found T2R38 in association with vesicles having the prop-
erties of lipid droplets. Lipid droplets were originally described
as lipid storage sites, but more recent studies described them as
functional organelles that actively participate in lipid turnover,
cellular signaling, and membrane trafficking (37, 38). As far as we
know, storage in or association with vesicles – lipid droplets or
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others – has not been investigated for T2R38 in its usual habitat –
that is, in cells of the taste buds – or in epithelial cells. Thus, the
question remains whether or not storage of T2R38 in vesicles is
typical for neutrophils or whether it is a general feature of T2R38
(our own not yet published data point to the latter).
Having established that T2R38 is present in neutrophils, the
question was addressed whether it is the receptor for AHL-12 on
these cells. LSM showed a co-localization of AHL-12 and T2R38,
and the “pull-down-assay” with biotin-labeled AHL-12 indicated
a physical interaction of AHL-12 with T2R38, which implies that
T2R38 is indeed the receptor for AHL-12 on neutrophils.
To link T2R38 to AHL-12 signaling, the effect of antibodies
to T2R38 on AHL-12-induced functions was tested. Only one of
the antibodies (sc-34294) inhibited binding of AHL-12 to some
extent, but not entirely. A likely explanation is the hydrophobic
nature of AHL-12, which allows attachment to cells and proba-
bly also partition into the membrane in a receptor-independent
manner. That the other antibodies – though binding to the cells –
did not block potential AHL-12 binding sites is in line with
data reported for ab65509 by others in another setting (32). As
anticipated, these antibodies did not inhibit AHL-12-mediated
activation of neutrophils.
The antibody sc-34294, which inhibitedAHL-12 binding, stim-
ulated neutrophils. The antibody by itself up-regulated CD11b cell
surface expression, and it enhanced phagocytosis, two functions
that are also induced by AHL-12. Thus, T2R38 is a functional
receptor on neutrophils, and according to the co-localization data,
AHL-12 is the most likely ligand.
Expression of T2R38 on neutrophils fits the concept that the
cells “sense” bacterial infection, and up-regulate defense-relevant
actions in consequence. In that, T2R38 qualifies as pathogen-
associated molecular pattern recognition receptor. Because bac-
teria produce and release AHL-12 as an autoinducer, crucially
required for biofilm formation, neutrophils will be attracted to
the infectious site before or concurrent with biofilm formation.
Because planktonic bacteria are in general more susceptible
to host defense mechanisms compared to bacteria organized
as biofilm, the infection can be cleared. Valid objections to
this notion are that micromolar concentrations of AHL-12 are
required to activate neutrophils – roughly 100- to 10,000-fold
more than for established chemokines – and that the weak to
moderate surface expression of T2R38 questions the effectiveness
of an AHL-12–T2R38 interaction. However, according to our
experience, AHL-12 is not very stable under cell culture condi-
tions, meaning that the abundance of active molecules might be
lower than the calculated input. In addition, local concentrations
of AHL-12 could be rather high, as data using supernatants of
biofilm-forming P. aeruginosa imply (20). Without question, the
biological relevance of our finding is still under scrutiny.
Our data, however, establish for the first time extra gustatory
expression of T2R38 on cells of the myeloid lineage, and are
compatible with the notion that T2R38 functions as a receptor
for AHL-12 on neutrophils as a novel means of recognizing of
bacterial components by the host defense.
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